Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Haas

Showing results (131-140 of 296) with videos related to

Pageof 30
Sort By:
Cancer|June 15, 2007
Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high-risk karyotypesSabine Knipp, Barbara Hildebrand, Andrea Kündgen, et al.
Nuclear Medicine and Biology|November 26, 2008
cis-4-[(18)F]-Fluoro-l-proline fails to detect peripheral tumors in humansGabriele Stoffels, Dirk Pauleit, Rainer Haas, et al.
Experimental Hematology|September 20, 2006
Sustained G-CSF plasma levels following administration of pegfilgrastim fasten neutrophil reconstitution after high-dose chemotherapy and autologous blood stem cell transplantation in patients with multiple myelomaRoland Fenk, Nadine Hieronimus, Ulrich Steidl, et al.
Stem Cells (Dayton, Ohio)|January 6, 2007
Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cellsMathias Witzens-Harig, Conny Heilmann, Manfred Hensel, et al.
European Journal of Haematology|June 25, 2009
Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromesJudith Neukirchen, Sabine Blum, Andrea Kuendgen, et al.
Cancers|April 13, 2024
Characterization of CD34<sup>+</sup> Cells from Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Using a t-Distributed Stochastic Neighbor Embedding (t-SNE) ProtocolCathrin Nollmann, Wiebke Moskorz, Christian Wimmenauer, et al.
Leukemia Research|April 7, 2007
Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcomeSabine Knipp, Corinna Strupp, Norbert Gattermann, et al.
Mechanisms of Ageing and Development|August 24, 2007
Age-related transcription levels of KU70, MGST1 and BIK in CD34+ hematopoietic stem and progenitor cellsWolf C Prall, Akos Czibere, Marcus Jäger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2011
The level of minimal residual disease in the bone marrow of patients with multiple myeloma before high-dose therapy and autologous blood stem cell transplantation is an independent predictive parameterMark Korthals, Nina Sehnke, Ralf Kronenwett, et al.
British Journal of Haematology|January 10, 2006
Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposalsUlrich Germing, Corinna Strupp, Andrea Kuendgen, et al.
Pageof 30

Showing results (131-140 of 296) with videos related to

Sort By:
Pageof 30
Cancer|June 15, 2007
Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high-risk karyotypesSabine Knipp, Barbara Hildebrand, Andrea Kündgen, et al.
Nuclear Medicine and Biology|November 26, 2008
cis-4-[(18)F]-Fluoro-l-proline fails to detect peripheral tumors in humansGabriele Stoffels, Dirk Pauleit, Rainer Haas, et al.
Experimental Hematology|September 20, 2006
Sustained G-CSF plasma levels following administration of pegfilgrastim fasten neutrophil reconstitution after high-dose chemotherapy and autologous blood stem cell transplantation in patients with multiple myelomaRoland Fenk, Nadine Hieronimus, Ulrich Steidl, et al.
Stem Cells (Dayton, Ohio)|January 6, 2007
Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cellsMathias Witzens-Harig, Conny Heilmann, Manfred Hensel, et al.
European Journal of Haematology|June 25, 2009
Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromesJudith Neukirchen, Sabine Blum, Andrea Kuendgen, et al.
Cancers|April 13, 2024
Characterization of CD34<sup>+</sup> Cells from Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Using a t-Distributed Stochastic Neighbor Embedding (t-SNE) ProtocolCathrin Nollmann, Wiebke Moskorz, Christian Wimmenauer, et al.
Leukemia Research|April 7, 2007
Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcomeSabine Knipp, Corinna Strupp, Norbert Gattermann, et al.
Mechanisms of Ageing and Development|August 24, 2007
Age-related transcription levels of KU70, MGST1 and BIK in CD34+ hematopoietic stem and progenitor cellsWolf C Prall, Akos Czibere, Marcus Jäger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2011
The level of minimal residual disease in the bone marrow of patients with multiple myeloma before high-dose therapy and autologous blood stem cell transplantation is an independent predictive parameterMark Korthals, Nina Sehnke, Ralf Kronenwett, et al.
British Journal of Haematology|January 10, 2006
Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposalsUlrich Germing, Corinna Strupp, Andrea Kuendgen, et al.
Pageof 30